Quillaic acid and echinocystic acid attenuate atherosclerosis: evidence from in vitro and in vivo studies
PeerJ · 12.11.2026 · 14 · e21907
DOI: 10.7717/peerj.21907 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, online erschienen am 12.11.2026. Verfasst von Jian Ai und 8 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province.
Abstract (Originalsprache)
Background
Atherosclerosis (AS) is an inflammatory disease characterized by the formation of lipid-laden lesions in arterial walls. Quillaic acid (QA) and echinocystic acid (EA) are natural pentacyclic triterpenes with diverse biological activities. However, whether QA and EA can ameliorate AS has not been reported.
Methods
In this study, we first investigated the effects of QA and EA in reducing foam cell accumulation and inflammation in vitro . Then, the therapeutic effects of QA and EA (i.p., 5 mg/kg) were evaluated in ApoE knockout (ApoE -/- ) mice fed a high-fat/high-cholesterol diet.
Results
In vitro experiments demonstrated that both QA and EA suppressed oxidized low-density lipoprotein (ox-LDL)-induced foam cell formation by inhibiting cholesterol uptake and also inhibited lipopolysaccharide (LPS)-induced inflammatory responses. In high-fat/high-cholesterol diet-fed ApoE -/- mice, QA or EA treatment significantly reduced serum lipid levels, decreased inflammatory factor release, and attenuated atherosclerotic plaque formation. At the tested dose, EA showed slightly better anti-inflammatory and plaque-reducing effects than QA. Transcriptomic profiling revealed enrichment of genes associated with “Cell adhesion molecules” and immune response pathways in the aorta of QA-treated mice. For EA, enrichment was observed for genes involved in “Circadian rhythms” in both liver and aorta, as well as genes related to “Vascular smooth muscle contraction” and the “cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG) signaling pathway” in aortic tissues. Real-time quantitative PCR (qPCR) analysis confirmed altered expression of selected circadian rhythm-related genes in the liver of EA- and QA-treated mice and in ox-LDL-induced foam cells. EA also increased cGMP levels in these foam cells.
Conclusions
This study provides the first evidence for the anti-atherosclerotic effects of QA and EA and offers new insights into the potential of natural products for the treatment of cardiovascular diseases.
Förderung
- National Key R&D Program of China
- Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province
Zitieren
APA
Ai, J., Tang, X., Zhou, Y., Liu, F., Mao, B., Zhang, Q., Zhao, J., Chen, W., & Cui, S. (2026). Quillaic acid and echinocystic acid attenuate atherosclerosis: evidence from in vitro and in vivo studies. PeerJ, 14, e21907. https://doi.org/10.7717/peerj.21907
Vancouver
Ai J, Tang X, Zhou Y, Liu F, Mao B, Zhang Q, et al. Quillaic acid and echinocystic acid attenuate atherosclerosis: evidence from in vitro and in vivo studies. PeerJ. 2026;14:e21907. doi:10.7717/peerj.21907
BibTeX
@article{Ai2026,
author = {Ai, Jian and Tang, Xin and Zhou, Yongkang and Liu, Fei and Mao, Bingyong and Zhang, Qiuxiang and Zhao, Jianxin and Chen, Wei and Cui, Shumao},
title = {Quillaic acid and echinocystic acid attenuate atherosclerosis: evidence from in vitro and in vivo studies},
journal = {PeerJ},
year = {2026},
volume = {14},
pages = {e21907},
doi = {10.7717/peerj.21907}
}
EUVIMED